About Elixir Medical
Elixir Medical is a company based in Sunnyvale (United States) founded in 2005. Elixir Medical has raised $5.3 million across 1 funding round from investors including Invus. The company has 70 employees as of December 31, 2022. Elixir Medical operates in a competitive market with competitors including S3V Vascular Technologies, Global Vascular, Medfavour and iVascular, among others.
- Headquarter Sunnyvale, United States
- Employees 70 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elixir Medcorp India Private Limited
- Date of Incorporation 02 Feb, 2012
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.3 M (USD)
in 1 rounds
-
Latest Funding Round
$5.3 M (USD), Series A
Mar 18, 2005
- Investors
-
Employee Count
70
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Elixir Medical
Unlock access to complete
Leadership Team
11 people
Sales and Marketing
6 people
Software Development Team
6 people
Operations Team
3 people
Product Management Team
2 people
Principal Team
2 people
Human Resources and Administration
2 people
Sr.scientist Team
1 people
Unlock access to complete
Funding Insights of Elixir Medical
Elixir Medical has successfully raised a total of $5.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.3 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elixir Medical
Elixir Medical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term private equity investments in transformational opportunities are pursued.
|
Locked | Locked | Locked |
Investor details for Elixir Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elixir Medical
Investment portfolio details for Elixir Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elixir Medical
Detailed financials for Elixir Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elixir Medical Comparisons
Peer comparison for Elixir Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elixir Medical
Elixir Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as S3V Vascular Technologies, Global Vascular, Medfavour and iVascular, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular surgical and critical care devices are developed and offered.
|
|
| Locked | Locked | Locked |
Drug-eluting stent systems for lower limb artery disease are developed.
|
|
| Locked | Locked | Locked |
Develops innovative technologies for drug-eluting stents to treat cardiac disorders.
|
|
| Locked | Locked | Locked |
Develops vascular medical devices for coronary, peripheral, and neurointerventionism treatments.
|
Detailed competitors of Elixir Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elixir Medical
Complete news archive for Elixir Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elixir Medical
Elixir Medical was founded in 2005.
Elixir Medical is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Elixir Medical is a funded company, having raised a total of $5.3M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Elixir Medical is 70.
Elixir Medical, a privately held company headquartered in Sunnyvale, CA, is developing drug-eluting stent systems. Key products include the Novolimus Eluting Stent System and Bioresorbable Coronary Scaffold System. The products are only approved for use outside the US.
Elixir Medical's top competitors include S3V Vascular Technologies, Global Vascular and Medfavour.
Elixir Medical has 1 investor. Key investors include Invus.